Our supportive findings lend weight to the argument that GSTT1 loss may serve as a useful genomic DNA biomarker to prospectively screen human donors before surgical isolation of bone marrow for hBMSC collection.
Less is more: Corroborating a genomic biomarker identifying human bone marrow multipotent stromal cells with high scalability
Burns J. S.
Primo
Writing – Original Draft Preparation
;
2020
Abstract
Our supportive findings lend weight to the argument that GSTT1 loss may serve as a useful genomic DNA biomarker to prospectively screen human donors before surgical isolation of bone marrow for hBMSC collection.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Burns & Kassem 2020.pdf
solo gestori archivio
Descrizione: Full text editoriale
Tipologia:
Full text (versione editoriale)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
849.11 kB
Formato
Adobe PDF
|
849.11 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
